Acurable

Acurable is a medical technology company founded in 2016 and based in London, with an additional office in Seville, Spain. The company specializes in developing wearable medical devices for home use, focusing on non-invasive, continuous monitoring and diagnostics for respiratory conditions, particularly sleep apnea. The flagship product line, AcuPebble®, utilizes patented wearable acoustic sensor technology to capture physiological signals from the body. These signals are processed using advanced algorithms to provide diagnostic outputs. Acurable's AcuPebble SA100 device is designed for the automated diagnosis of obstructive sleep apnea in adults, while the AcuPebble RE100 is intended for continuous monitoring in research settings. The devices have received regulatory approvals, including the CE mark for Europe and FDA 510(k) clearance for the USA. Acurable's research and development are conducted at its headquarters within the Imperial College White City Incubator, fostering a collaborative environment focused on scientific innovation. The company aims to enhance healthcare accessibility and patient-centric solutions through earlier detection and better management of chronic conditions.

• Employees 32
• Founded 2016
• Annual Revenue $1000000
• Total Funding $15031584